Space Oncology: Using Microgravity for Advanced Cancer Research

#GS-3 #Science & Technology #Biotechnology #Space #Health #Current Events #National

Why in News

Cancer remains a severe global health crisis, and experts estimate that India alone will see nearly **1.87 million** new cases in **2026**. This rising burden causes huge medical expenses and financial loss for families.
To tackle this problem, **space oncology** has emerged as a promising new scientific field. Researchers use **microgravity** in space to study how tumours grow and to design better cancer medicines.

**Space oncology** is a modern branch of science that studies how space conditions affect cancer cell behavior. It examines the impact of **microgravity** and cosmic radiation on tumour growth and treatment response.
Outer space acts as an ideal natural laboratory for medical researchers. It helps scientists observe how cancer spreads, resists drugs, and responds to radiation treatments.
This research helps scientists develop advanced **3D cell cultures** and **tumour spheroids**. It also improves protein crystallization and accelerates the creation of effective new drugs.

India faces a rapidly growing health challenge, with predictions showing nearly **1.87 million** new cancer cases in **2026**. This huge increase highlights the urgent need for revolutionary treatment methods.
Cancer causes severe financial damage to families through expensive treatment costs and loss of earning capability. It also creates long-term mental and financial stress for caregivers.
Studying cancer in space gives researchers realistic tumour models. These advanced models help scientists understand basic disease mechanisms much faster than traditional laboratory tools.
**Microgravity** testing improves drug formulations and makes drug delivery systems more precise. This approach can also reduce our reliance on testing medicines on animals.

When cancer cells enter **microgravity**, their internal structures undergo significant changes. Their cytoskeleton reorganizes and changes how cells attach to their surrounding tissue.
These gravity changes directly alter how cancer cells grow, divide, and move. They also change gene expression patterns inside the malignant cells.
**Microgravity** allows cancer cells to cluster into realistic three-dimensional structures called **tumour spheroids**. These structures closely mimic how actual tumours behave inside the human body.
Structural shifts in cells change how easily cancer medicine can enter them. This helps researchers discover why certain drug therapies succeed or fail.

In breast cancer research, **microgravity** alters cell migration and cycle regulation. This makes breast cancer spheroids more vulnerable to specialized therapy drugs.
Certain gastrointestinal cancer cells change their growth behavior in space. They show reduced drug resistance, allowing medicines to target and destroy them more effectively.

India can combine **ISRO** space expertise with its growing commercial space industry to create modern space-based biomedical research facilities.
The government can encourage pharmaceutical companies to conduct space-based research for novel drug formulations and microgravity manufacturing.
Strong partnerships between **ISRO**, medical hospitals, pharmaceutical firms, and space startups can speed up practical discoveries in cancer research.
India can focus on transforming space research into affordable cancer diagnostic tools and treatments to reduce expenses for local patients.
With declining rocket launch costs and expanding space access, India can position itself as a global leader in space biotechnology.